Risk and Response-Adapted Treatment in Multiple Myeloma.

Cazaubiel, Titouan; Mulas, Olga; Montes, Lydia; Schavgoulidze, Anaïs; Avet-Loiseau, Hervé; Corre, Jill; Perrot, Aurore

Cazaubiel, Titouan; Mulas, Olga; Montes, Lydia; Schavgoulidze, Anaïs; Avet-Loiseau, Hervé; Corre, Jill; Perrot, Aurore.

Afiliación

Cazaubiel T; Hematology Department, University Hospital, 33600 Bordeaux, France.
Mulas O; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, 31059 Toulouse, France.
Montes L; Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari, 09124 Cagliari, Italy.
Schavgoulidze A; Hematology Department, University Hospital, 80054 Amiens, France.
Avet-Loiseau H; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, 31059 Toulouse, France.
Corre J; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, 31059 Toulouse, France.
Perrot A; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, 31059 Toulouse, France.

Cancers (Basel) ; 12(12)2020 Nov 24.

Article en En | MEDLINE | ID: mdl-33255368

Palabras clave

cytogenetics; multiple myeloma; personalized therapy; response-adapted treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google